Trials / Recruiting
RecruitingNCT05729932
Cannabis and Opioid Use Disorder
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- University of Kentucky · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled vaporized cannabis | Double-blind cannabis and placebo doses, administered through vaporizer |
| DRUG | Intransal opioid | Double-blind opioid and placebo doses, administered intranasal route |
Timeline
- Start date
- 2024-09-10
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2023-02-15
- Last updated
- 2025-12-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05729932. Inclusion in this directory is not an endorsement.